GLENN DAVIS: Open Payments
NPI 1932277654 · MOUNT VERNON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,368 in 149 payments from 20 companies in 2025. Trend: 2023 $4,952 · 2024 $3,752 · 2025 $4,368
Food & beverage: $4,368
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $801 |
| ABBVIE INC. | 25 | $638 |
| GENZYME CORPORATION | 4 | $387 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $372 |
| GlaxoSmithKline, LLC. | 14 | $278 |
| Amgen Inc. | 2 | $250 |
| Boston Scientific Corporation | 9 | $249 |
| Exact Sciences Corporation | 9 | $236 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $225 |
| PFIZER INC. | 11 | $209 |
Products named: JARDIANCE, DUPIXENT, AIRSUPRA, UBRELVY, TEPEZZA, WATCHMAN FLX, FARXIGA, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
